日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epithelial polarization in the 3D matrix requires MST3 signaling to regulate ZO-1 position

3D 基质中的上皮极化需要 MST3 信号来调节 ZO-1 的位置

Chee-Hong Chan, Pei Lin, Tse-Yen Yang, Bo-Ying Bao, Jhen-Yang Jhong, Yui-Ping Weng, Te-Hsiu Lee, Hui-Fen Cheng, Te-Ling Lu

Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice

丙咪嗪加速肥胖小鼠的非酒精性脂肪肝疾病、肾功能损害、糖尿病视网膜病变、胰岛素抵抗和尿铬流失

Geng-Ruei Chang, Po-Hsun Hou, Chao-Min Wang, Jen-Wei Lin, Wei-Li Lin, Tzu-Chun Lin, Huei-Jyuan Liao, Chee-Hong Chan, Yu-Chen Wang1

Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice

氯氮平加重肥胖小鼠的葡萄糖不耐症、非酒精性脂肪肝、肾脏损伤和视网膜损伤,并增加肾脏活性氧的产生和铬的流失

Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Lin

MST3 Involvement in Na+ and K+ Homeostasis with Increasing Dietary Potassium Intake

随着膳食钾摄入量的增加,MST3 参与 Na+ 和 K+ 稳态

Chee-Hong Chan, Sheng-Nan Wu, Bo-Ying Bao, Houng-Wei Li, Te-Ling Lu

Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor

托伐普坦(一种血管加压素 V2 受体的非肽拮抗剂)有效抑制多种 K+ 电流的证据

Te-Ling Lu, Wei-Ting Chang, Chee-Hong Chan, Sheng-Nan Wu

MST3 is involved in ENaC-mediated hypertension

MST3 参与 ENaC 介导的高血压

Te-Jung Lu, Wei-Chih Kan, Sung-Sen Yang, Si-Tse Jiang, Sheng-Nan Wu, Pin Ling, Bo-Ying Bao, Chia-Yu Lin, Zin-Ya Yang, Yui-Ping Weng, Chee-Hong Chan, Te Ling Lu